News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,471 Results
Type
Article (87925)
Company Profile (825)
Press Release (780705)
Multimedia
Podcasts (193)
Webinars (28)
Section
Business (233247)
Career Advice (4146)
Deals (39872)
Drug Delivery (147)
Drug Development (91405)
Employer Resources (204)
FDA (18380)
Job Trends (17424)
News (397875)
Policy (39962)
Tag
Academia (3008)
Academic (2)
Accelerated approval (33)
Adcomms (36)
Allergies (144)
Alliances (56981)
ALS (180)
Alzheimer's disease (1785)
Antibody-drug conjugate (ADC) (337)
Approvals (18551)
Artificial intelligence (616)
Autoimmune disease (155)
Automation (35)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (199)
Biotechnology (490)
Bladder cancer (161)
Brain cancer (65)
Breast cancer (650)
Cancer (4954)
Cardiovascular disease (437)
Career advice (3568)
Career pathing (41)
CAR-T (302)
CDC (59)
Celiac Disease (1)
Cell therapy (819)
Cervical cancer (37)
Clinical research (76925)
Collaboration (1765)
Company closure (5)
Compensation (1138)
Complete response letters (70)
COVID-19 (2989)
CRISPR (97)
C-suite (832)
Cystic fibrosis (154)
Data (6169)
Decentralized trials (2)
Denatured (70)
Depression (149)
Diabetes (528)
Diagnostics (7210)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (297)
Drug pricing (221)
Drug shortages (36)
Duchenne muscular dystrophy (234)
Earnings (100053)
Editorial (61)
Employer branding (25)
Employer resources (173)
Events (134988)
Executive appointments (1027)
FDA (21482)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1535)
Gene editing (211)
Generative AI (63)
Gene therapy (661)
GLP-1 (1111)
Government (5434)
Grass and pollen (8)
Guidances (383)
Healthcare (20942)
HIV (60)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (287)
Immuno-oncology (56)
Indications (85)
Infectious disease (3273)
Inflammatory bowel disease (203)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (241)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5199)
Job search strategy (2866)
Kidney cancer (17)
Labor market (90)
Layoffs (658)
Leadership (39)
Legal (10158)
Liver cancer (98)
Longevity (14)
Lung cancer (676)
Lymphoma (372)
Machine learning (44)
Management (66)
Manufacturing (825)
MASH (172)
Medical device (15008)
Medtech (15052)
Mergers & acquisitions (22962)
Metabolic disorders (1374)
Multiple sclerosis (159)
NASH (23)
Neurodegenerative disease (344)
Neuropsychiatric disorders (93)
Neuroscience (3078)
NextGen: Class of 2026 (7707)
Non-profit (5110)
Now hiring (63)
Obesity (661)
Opinion (332)
Ovarian cancer (164)
Pain (200)
Pancreatic cancer (227)
Parkinson's disease (291)
Partnered (39)
Patents (493)
Patient recruitment (462)
Peanut (60)
People (66831)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23776)
Phase II (33374)
Phase III (25161)
Pipeline (4765)
Policy (330)
Postmarket research (3554)
Preclinical (10686)
Press Release (72)
Prostate cancer (241)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (874)
Real estate (7437)
Recruiting (80)
Regulatory (28904)
Reports (66)
Research institute (2722)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (157)
Series A (255)
Series B (193)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (98)
The Weekly (121)
Vaccines (1134)
Venture capital (92)
Weight loss (457)
Women's health (85)
Worklife (21)
Date
Today (124)
Last 7 days (372)
Last 30 days (2063)
Last 365 days (33212)
2026 (1784)
2025 (33226)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (88)
Alaska (7)
Arizona (340)
Arkansas (14)
Asia (51512)
Australia (9041)
California (11366)
Canada (3278)
China (1142)
Colorado (483)
Connecticut (496)
Delaware (342)
Europe (118336)
Florida (1661)
Georgia (366)
Hawaii (3)
Idaho (68)
Illinois (949)
India (66)
Indiana (537)
Iowa (24)
Japan (416)
Kansas (133)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1444)
Massachusetts (8406)
Michigan (353)
Minnesota (656)
Mississippi (6)
Missouri (138)
Montana (35)
Nebraska (29)
Nevada (123)
New Hampshire (85)
New Jersey (3072)
New Mexico (33)
New York (3011)
North Carolina (1592)
North Dakota (10)
Northern California (5423)
Ohio (349)
Oklahoma (22)
Oregon (54)
Pennsylvania (2279)
Puerto Rico (21)
Rhode Island (50)
South America (1657)
South Carolina (63)
South Dakota (1)
Southern California (4379)
Tennessee (174)
Texas (1794)
United States (41126)
Utah (341)
Vermont (1)
Virginia (285)
Washington D.C. (86)
Washington State (957)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
There are 869,471 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ascelia Pharma Announces Deputy CEO Julie Waras Brogren to Leave the Company
January 21, 2026
·
1 min read
Press Releases
Senzime Secures Major Ivy League US Hospital System Contract
January 21, 2026
·
2 min read
Press Releases
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
January 21, 2026
·
5 min read
Press Releases
FluoGuide Submits an IND for FG001, to Initiate First U.S. Registration Trial
January 21, 2026
·
3 min read
Press Releases
FDA Granted Hopstem’s hNPC01 for Chronic Ischemic Stroke Approval to Enter Phase 2/3 Adaptive Pivotal Clinical Trial with Bridging Study
January 21, 2026
·
5 min read
Press Releases
Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics
January 21, 2026
·
4 min read
Cell therapy
After Cell Therapy Retreat, Novo Offloads Technologies in Deepened Aspect Pact
Novo Nordisk pulled back from cell therapies last October, scrapping development of a type 1 diabetes therapy and laying off most employees working on this modality.
January 21, 2026
·
2 min read
·
Tristan Manalac
Government
Rare Pediatric Disease Vouchers, PBM Reform, up for Vote in House
A renewal of the FDA’s pediatric rare disease voucher program is couched within a massive $1.2 trillion spending bill the House is set to vote on later this week.
January 21, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Roche Raises NC Manufacturing Investment to $2B To Support Obesity Challenge
Genentech, a member of the Roche Group, plans to open the facility in 2029 to ramp up capacity to make obesity candidates, including the dual GLP-1/GIP receptor agonist CT-388.
January 21, 2026
·
2 min read
·
Nick Paul Taylor
Collaboration
GSK Joins Growing PD-1 SubQ Push With Alteogen Alliance Worth up to $285M+
Ahead of GSK are Bristol Myers Squibb and Merck, which have already won FDA approvals for subcutaneous formulations of their respective PD-1 blockers Opdivo and Keytruda.
January 21, 2026
·
1 min read
·
Tristan Manalac
1 of 86,948
Next
